Northwell Health North Shore/Long Island Jewish General Surgery, 300 Community Drive, Manhasset, NY, 11030, USA.
Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, 500 Hofstra Blvd, Hempstead, NY, 11549, USA.
BMC Pediatr. 2023 Mar 24;23(1):134. doi: 10.1186/s12887-023-03932-3.
To examine the use of abdominal ultrasound (AUS) as a diagnostic adjunct in the diagnosis of necrotizing enterocolitis (NEC) in cases where abdominal radiography (AXR) is equivocal in order to reduce unnecessary antibiotic use in neonates.
Retrospective study (2017-2019) of infants undergoing NEC evaluation with equivocal AXR findings (n = 54). Paired AXR and AUS were reviewed with respect to presence or absence of pneumatosis. Concordance of AUS findings with decision to treat for NEC was evaluated.
Among 54 infants where AXR was equivocal, AUS demonstrated presence of pneumatosis in 22 patients (41%), absence of pneumatosis in 31 patients (57%), and was equivocal in 1 patient. All patients with pneumatosis on AUS were treated for NEC. Of 31 patients without pneumatosis on AUS, 25 patients (78%) were not treated for NEC. Patients without pneumatosis on AUS received a significantly shorter mean duration of antibiotics compared to those with pneumatosis (3.3 days (+/- 4.8 days) vs 12.4 days (+/- 4.7 days)); p < 0.001). Of those patients not treated, none required treatment within 1 week following negative AUS.
AUS is a valuable tool for evaluating the presence or absence of pneumatosis in the setting of equivocal AXR. Absence of pneumatosis on AUS informs clinical decision making and reduces unnecessary treatment and antibiotic usage.
为了在腹部 X 光(AXR)结果不确定的情况下,检查腹部超声(AUS)作为诊断辅助手段在坏死性小肠结肠炎(NEC)诊断中的应用,以减少新生儿不必要的抗生素使用。
回顾性研究(2017-2019 年)对疑似 NEC 患儿进行评估,AXR 结果不确定(n=54)。回顾性分析 AXR 和 AUS 有无气肿的表现。评估 AUS 与 NEC 治疗决策的一致性。
在 54 例 AXR 结果不确定的婴儿中,AUS 显示 22 例(41%)存在气肿,31 例(57%)不存在气肿,1 例不确定。所有 AUS 显示气肿的患者均接受 NEC 治疗。31 例 AUS 无气肿的患者中,25 例(78%)未接受 NEC 治疗。AUS 无气肿的患者接受抗生素治疗的平均时间明显短于有气肿的患者(3.3±4.8 天 vs 12.4±4.7 天);p<0.001)。未接受治疗的患者中,无一例在 AUS 阴性后 1 周内需要治疗。
AUS 是评估 AXR 结果不确定时是否存在气肿的有价值工具。AUS 无气肿有助于临床决策,减少不必要的治疗和抗生素使用。